G
Genomic Life
Provides genomic screenings and personalized cancer navigation services to help individuals, employees, and communities manage genetic disease and cancer risks, improving health outcomes
About Genomic Life
Genomic Life operates on a B2B2C model, providing its services primarily through employer-sponsored health benefits programs. The company partners with businesses to offer their employees access to proactive genetic testing and personalized health guidance.
Individuals who enroll in the program can access genetic screenings to identify inherited risks for various diseases, particularly cancer. Beyond testing, the company provides personalized navigation and ongoing support to help users and their healthcare providers interpret the genetic insights and turn them into actionable clinical plans for preventative care and early detection. This includes tailored support for those with a higher risk of or a current diagnosis of cancer.
By integrating with employee benefits packages, Genomic Life aims to make genomic medicine more accessible, enabling a larger population to take proactive steps in managing their long-term health and wellbeing.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2017
- Headquarters
- San Diego, United States
- Employees
- 43
- Open positions
- None listed
- Dealroom signal
- 45.0/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Oncology, Genetics and genomics, Genome Engineering, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VCOther financing | May 2024 | $10M | $40M | Undisclosed | ↗ |
| SEEDOther financing | Aug 2017 | $0 | — | Farmington Capital Partners | — |
Growth signals
Latest recorded traffic for Genomic Life is 5.3K monthly website visits, up 29.3% over the last three months. Genomic Life's team grew 4.9% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
- FPFarmington Capital Partners
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Genomic Life on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Genomic Life’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.